Sheri Lewis serves as Chief Operations, Quality, and Technology Officer at The Beauty Health Company (Class A shares), where she leads global operations, quality assurance, regulatory compliance, and technology initiatives. With over 25 years of experience in the medical device and aesthetics industries, Sheri has built a distinguished career focused on scaling operations, ensuring product safety, and driving innovation. She joined Beauty Health in 2021 as Chief Quality Officer before ascending to her current role, bringing expertise in building robust quality management systems and navigating complex regulatory landscapes across multiple geographies. Prior to Beauty Health, Sheri held senior leadership positions at Penumbra, Inc., as Vice President of Quality and Regulatory Affairs, where she spearheaded the company's quality transformation and supported rapid growth through successful FDA audits and international certifications. Her earlier roles at Nevro Corp. and Boston Scientific honed her skills in operations optimization, risk management, and supply chain resilience, contributing to multiple product launches and market expansions. Recognized for her strategic foresight, Sheri has been instrumental in achieving ISO 13485 certification and advancing digital transformation efforts at previous organizations. At Beauty Health, Sheri oversees the end-to-end operations for the company's flagship HydraFacial brand, enhancing manufacturing efficiency, technology integration, and quality standards to support global distribution. Her leadership has been pivotal in maintaining high compliance during periods of accelerated growth, positioning the company for sustained innovation in non-invasive aesthetic solutions. A certified quality professional, Sheri is passionate about fostering a culture of excellence and continuous improvement.